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Mortality from cancers of the oral cavity and pharynx, oesphagus, larynx and lung between 1955 and 1989 has been
analysed for USA, Canada and 14 countries in Latin America. Among males, Uruguay, Cuba, Argentina and Puerto
Rico have the highest rates for all sites, and Peru, Ecuador, Dominican Republic, Mexico and Colombia have the lowest
rates. Among females, Cuba, Colombia and Puerto Rico rank high for all sites, and Mexico, Paraguay, Ecuador and
Peru rank low. For both sexes, lung cancer mortality rates from the US and Canada are high, whereas rates from other
sites are intermediate. An increasing trend in lung cancer mortality over time is shown in all countries except Cuba (no
changes), Argentina, Paraguay and Peru (decreasing trend). In Latin America, the tobacco-related lung cancer
epidemic is in its early phase among males, and very early phase among females.
Consumption of tobacco and its health effects have
been widely investigated in the US and Canada: on the
other hand, little is known about smoking-related
diseases in Central and South American countries. In
particular, little information is available on the occur-
rence of tobacco-related cancers.1 This study has been
carried out to investigate how routine mortality data
can be used to estimate the importance of tobacco-
related cancers in developed as well as developing
American countries. Cancers of the lung and of the
upper respiratory and digestive tract have been con-
sidered. Lung cancer has been given specific attention
because it is the single most important tobacco-related
disease not appreciably influenced by alcohol or mate
drinking or other major lifestyle risk factors, and a
major cause of illness and premature death as well as
of health-related costs. In addition lung cancer mor-
tality is close to incidence because of poor survival
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rates, and the seriousness of the disease makes the
diagnosis more reliable than for other conditions,
especially in the 35-64 age group.
MATERIALS AND METHODS
Death certification figures for cancers of the oral
cavity and pharynx (International Classification of
Diseases, ICD—9, 140-148), oesophagus (ICD—9,
150), larynx (ICD—9, 161) and lung (ICD—9, 162),
stratified for sex and 5-year age groups for selected
American countries were derived from the World
Health Organization database, March 1991 version.
During the period considered (1955-1989), four dif-
ferent revisions of the International Classification of
Diseases were used in the different countries.2 Conver-
sion programmes were used to obtain consistent figures
across the different revisions.
The WHO database also contains sex- and age-
specific estimates of the resident population, based on
official censuses. For each calendar year, and for each
quinquennium, sex-specific age-standardized mortality
rates were calculated using the weights of the World
standard population.3 Truncated rates for the 35-64
year age group were also calculated.
The WHO database contains some data on mortality
or population for 49 American countries or territories.
377
378 INTERNATIONAL JOURNAL OF EPIDEMIOLOGY
Excluded were all areas with <2000000 population.
Out of the 24 countries left, only those with age-
stratified mortality and population figures of sufficient
detail were retained: eight countries (Bolivia, Brazil, El
Salvador, Guatemala, Haiti, Honduras, Jamaica,
Nicaragua) were excluded at this stage. The analysis is
based on the remaining 16 countries: Argentina,
Canada, Chile, Colombia, Costa Rica, Cuba,
Dominican Republic, Ecuador, Mexico, Panama,
Paraguay, Peru, Puerto Rico (a self-governing Com-
monwealth), US, Uruguay, and Venezuela.
In most countries, data were missing for one or
more years within the study period. When a single year
was missing, numerators and denominators for each
5-year age group were interpolated from the previous
and subsequent calendar year.
Apart from the US and Canada, few populations in-
cluded in this study were covered by a Cancer Registry:
La Plata, Argentina (1980), Chile (1959-1962), Cali,
Colombia (1962-1981), Costa Rica (1980-1982), Cuba
(1968-1977), Panama (1974-1980) Paraguay (three
departments) (1975-1977), and Lima, Peru (1978). In
these cases, comparisons were made between incidence
and mortality rates. Incidence rates were derived from
IARC publications.1'3"6 In the case of registries not
covering the entire national population, the com-
parison was made with national mortality figures.
RESULTS
Sex-specific, age-standardized mortality rates for
cancer of the oral cavity and pharynx, oesophagus,
larynx, and lung during the most recent calendar
period available are shown in Figures 1-4, respectively.
For all sites, and in both sexes, the ratio of the highest
versus the lowest rates is approximately 10. Among
males, rates from Uruguay, Cuba, Argentina and
Puerto Rico tend to be among the highest for all sites,
whereas Peru, Ecuador, Dominican Republic, Mexico
and Colombia are consistently among the countries
with lowest mortality. Mortality rates for cancer of
mouth and pharynx, oesophagus and larynx from the
US and Canada are intermediate.
On the other hand, lung cancer mortality in these
two countries is comparable to that of Uruguay (i.e.
around or over 55/100000, World standard) and
higher than those of all remaining countries. Thus, in
the late 1980s overall age-adjusted (World population)
lung cancer rates in males were 15-22/100000 in Chile,
Costa Rica, Panama, Puerto Rico and Venezuela, and
around or below 10/100000 in Colombia, the
Dominican Republic, Ecuador, Paraguay and Peru.
Among women, Cuba, Colombia and Puerto Rico
tend to have higher mortality rates for all considered
sites, whereas Mexico, Paraguay, Ecuador and Peru
tend to score towards the bottom of all ranking. The
US and Canada again have the highest mortality rates
for lung cancer.
Figure 5 shows trends in lung cancer mortality rates
by calendar quinquennium in men and women. In
the late 1960s, Argentina had an overall World-
standardized lung cancer mortality rate for males of
> 45/100 000, and the rate for Uruguay and Cuba was
>40/100000, i.e. two of the highest lung cancer rates
in that period. Lung cancer mortality however, has
since then been stable in Cuba and has declined in
Argentina (to 39.7/1OOOO0 in males in 1985-1989) and
is now, therefore, substantially lower than the values
of 56-57/100000 for the US and Canada. A positive
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FIGURE 1 Age-standardized mortality rates for cancer of oral cavity and pharynx in 16 American countries
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FIGURE 2 Age-standardized mortality rates for cancer of oesophagus in 16 American countries
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FIGURE 3 Age-standardized mortality rales for cancer of larynx in 16 American countries
LUNG, MALES
0 10 20 30
USA (198548)
CANADA (198548)
URUGUAY (198547)
ARGENTINA (198548)
CUBA (198548)
CHILE (198547)
PUERTO FBCO (198547)
COSTA RICA (198548)
VENEZUELA (198547)
MEXICO (198548)
PANAMA (198547)
PARAGUAY (198548)
COLOMBIA (1875-77)
ECUADOR (198548)
DOMNICAN REPUBLIC (1985)
PERU (198043)
LUNG, FEMALES
0 10 20 30 40 50
USA (1885-88)
CANADA (1985 88)
CUBA (198548)
VENEZUELA (198547)
PUERTO RICO (198547)
CH I E (198547)
COSTA RICA (198548)
MEXICO (198546)
ARGENTINA (198548)
COLOMBIA (1975-77)
PANAMA (198547)
URUGUAY (198547)
ECUADOR (1S8548)
PERU( 198043)
PARAGUAY (198548)
DOMINICAN REPUBLIC (1985)
FIGURE 4 Age-standardized mortality rales for cancer of lung in 16 American countries
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TABLE 1 Comparison of lung cancer mortality and incidence rates
Argentina
Chile
Colombia"
Costa Rica
Cuba
Panama
Paraguay
Peruc
Years
1980
1959-1961
1977
1972, 1975, 1976
1967-1969
1962-1964
1980-1982
1973-1977
1968, 1971, 1972
1974, 1980
1975, 1977
1977
Mortality
Males
43.8
13.4
10.1
8.7
7.4
4.3
15.7
38.9
39.3
14.3
10.2
6.4
Females
5.2
4.7
5.1
4.4
3.2
2.0
7.4
14.4
14.4
3.7
2.5
2.9
Years
1980
1959-1961
1977-1981
1972-1976
1967-1971
1962-1964
1980-1982
1973-1977
1968-1972
1974-1980
1975-1977
1978
Incidence
Males
40.3
8.5
25.4
19.5
19.4
6.8
17.8
44.4
38.1
5.1
8.1
18.2
Females
6.7
2.8
9.7
5.4
2.6
1.9
6.8
16.9
12.9
1.8
1.9
5.7
•incidence data from the city of Cali only.
''Incidence data from three departments only,
incidence data from Lima metropolitan area only.
(i.e. increasing over time) trend among men was found
in Chile, Colombia, Costa Rica, Dominican Republic,
Ecuador, Mexico, Panama, Puerto Rico, Uruguay,
and Venezuela. In three countries, Argentina (starting
from high values), Paraguay and Peru (whose rates
have remained substantially low), a decreasing trend is
shown, and in Cuba no modification was suggested.
Among women, rates were increasing during the study
period in Chile, Colombia, Costa Rica (not in the
35-64 year age group), Mexico, Panama, and
Venezuela, as well as Canada and the US. Absolute
values in all Latin America except Cuba were however
substantially lower than in the US or Canada. Argen-
tina was the only country showing a significant
downward trend.
The comparison of lung cancer mortality and in-
cidence data for areas and calendar periods covered by
cancer registries is shown in Table 1. Overall, the cor-
respondence between the two sets of data is very good.
Incidence data from Colombia and Peru are higher
than mortality figures, whereas the opposite is true for
Panama.
DISCUSSION
The quality of death certification and in particular the
accuracy of the diagnosis of cancer of the lung and
other organs in the 16 countries included in the study is
an important problem in the interpretation of the
results. Two aspects can be identified: comparability
of quality among countries and variation with time
within countries. A further possible source of bias are
differences in the completeness of census data. A par-
tial assessment of the quality of the mortality rates
calculated in the present study can be derived from the
comparison of mortality and incidence rates (Table 1).
The high level of agreement adds to the validity of the
mortality data from those countries with a nationwide
register (i.e. Chile, Costa Rica and Cuba). In Colom-
bia and Peru incidence rates are much higher than
mortality rates, but only urban areas (Cali and Lima,
respectively) were covered by cancer registration. The
discrepancy between incidence and mortality data
from Panama can be explained by incomplete coverage
of the Registry1 or by instability of mortality rates,
which are based on 2 years only.
Mortality rates of upper aero-digestive cancers from
the US and Canada are intermediate when compared
with those from most Latin American countries in-
cluded in this study (Figures 1-3). Similarly, values
shown in Figures 1-3 are similar to rates calculated for
European Community (EC) countries: as an example,
mortality rates for oesophageal cancer in EC countries
during 1980-1984 ranged from 1.9 to 13.0/
100000/year among males and from 0.5 to 3.9/
100000/year among females. '•' For lung cancer, on the
other hand, mortality rates for the US and Canada
tend in both sexes to be much higher than those for
most of the Latin American countries analysed; 1980-
1984 EC rates are 53.0/lOOOOO/year among males and
8.2/100000/year among females, values which are
higher than those of all but one Latin American
country included in this study, and comparable to
North American rates.
Data on tobacco consumption suggest a wide varia-
tion in cigarette smoking among American countries;
Cuba, Canada and the US being the countries with the
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FIGURE 7 Prevalence of smokers in eight Latin American populations, 1971
highest consumption and Central American and An-
dean countries being those with the lowest (Figure 6).
Even if these data may have some limitations, the wide
range of values in cigarette consumption seems consis-
tent with the range of values of mortality from
tobacco-related cancers. Only one international survey
on smoking habits is available from Latin America.l0
Over 9400 people aged 15-74 from eight urban areas
(Bogota; Caracas; Guatemala City; La Plata, Argen-
tina; Lima; Mexico City; Santiago; Sa"o Paulo, Brazil)
were interviewed in 1971 (response rate 90%). The
prevalence of current smokers among males ranged
from 34.2% in Lima to 57.9% in La Plata, and in
women between 6.5% in Lima and 26.4% in Santiago
(Figure 7). In all cities (except S3o Paulo), and in both
sexes, there were more ever smokers among individuals
40-54 years old than among individuals aged 55-74,
suggesting an increasing proportion of smokers among
younger cohorts. The average number of cigarettes per
day in Latin America, however, was substantially
lower than in the US or Canada. The proportion of
smokers of unfiltered cigarettes among males ranged
from 3.9% (Caracas) to 28.0% (Sa"o Paulo), and in
women from 4.0% (Bogota) to 23.5% (Caracas).
Although some mortality or incidence data have
been published for individual countries or areas, such
as La Paz," Chile,12-14 Cali, Colombia,13 Antioquia,
Colombia,16 Argentina,17 and data from the US or
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Canada are well known, our study provides the first
comprehensive report on mortality from lung and
other tobacco-related cancers in the Americas. The
high variability in lung cancer mortality among
American countries might be due in part to bias in
death certification, but it is likely to reflect true
variability in the effects of tobacco smoking and other
carcinogens. A number of case-control studies have
been conducted in Latin American countries on cancer
of the lung,18-" larynx,*° oesophagus,2I oral cavity,22-23
and multiple sites;24 these studies showed that con-
sumption of tobacco products is an important risk fac-
tor and colour of tobacco (black versus blond)25 is an
important aspect of the carcinogenic risk from tobacco
smoking in these countries. The studies also showed a
carcinogenic effect of other lifestyle factors, such as
diet, alcoholic beverages and mate drinking, par-
ticularly on cancers of the digestive tract. Occupa-
tional exposures were also shown to play some role. In-
ternational studies carried out in areas of low and high
incidence of mortality for lung and other tobacco-
related cancers might help to elucidate the role of
tobacco and other risk factors in the aetiology of these
neoplasms in different American countries.
On a public health scale, however, it is apparent
that, whereas cancers of the oral cavity, oesophagus
and larynx are a major issue in several Latin American
countries, the tobacco-related lung cancer epidemic is
still in its early phases in males, and very early phases
in females, in these populations. There is, therefore,
ample scope for intervention to avoid the future spread
of this epidemic.
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